COPD Data, Analysts, Treg Cell Therapy Deal Lift Regeneron

The largest biopharmas hardly budge much in terms of stock prices from week to week, so it’s reason to take notice when shares of Regeneron Pharmaceuticals (REGN) jump by double digits over a few days.
Regeneron finished trading Tuesday at $826.97, up 10% from $751.30 on March 23, the…

Source: www.genengnews.comRead more